Raporty

7/2012 Significant agreement with the National Health Fund

The Management Board of Centrum Medyczne ENEL-MED S.A. (the Company) reports that on 22 February 2012 the company received signed annexes to agreements concluded with the National Health Fund. As a result, the total value of the agreements concluded between the Company and the National Health Fund in the period from 13 June 2011 to 22 February 2012 amounted to PLN 12.843.348,60 net, and thus exceeded the threshold of 10 percent of the Company’s equity, i.e. the amount of PLN 5.276.000. On 30 September 2011, the Company’s equity amounted to PLN 52.760.000.

During this period, the largest agreement was valued at PLN 3.219.183,00 net and was signed as of 3 February 2012. The agreement was concluded between the National Health Fund – Masovian Voivodeship Branch and the Company. The maximum value of the liabilities of the Fund’s Branch towards the Company for implementation of the agreement amounts to PLN 1.609.677,00 for the period from 1 January 2012 to 30 June 2012 and PLN 1.609.506,00 for the period from 1 July 2012 to 31 December 2012.

The subject of this agreement is provision by the Company of health care services in the field of outpatient specialist care, including in particular endoscopic, magnetic resonance imaging and computed tomography examinations.

The agreement provides for the following contractual penalties for the Company:

a)    in the case of issuing prescriptions to unauthorised persons or in the case of issuing prescriptions in unjustified cases, the Fund’s Branch may impose on the Service Provider a contractual penalty equivalent to the undue reimbursement of medicines made on the basis of the prescriptions, including statutory interest accrued from the date of the reimbursement;

b)    in the case of issuing orders for the supply of medical devices being orthopaedic items or of aids financed in whole or in part by the National Health Fund, the Fund’s Branch may impose on the Service Provider a contractual penalty equivalent to the amount of the undue financing, including statutory interest accrued from the date of the reimbursement.

The terms of the agreement, including the specific penalties defined therein, do not differ from market standards.